Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Thomas Hogberg"'
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Despite improved surgical and oncological treatment, ovarian cancer continues to be the most lethal of the gynecologic malignancies. We aimed to analyze survival trends in epithelial ovarian cancer with regard to age, tumor site,
Externí odkaz:
https://doaj.org/article/98fbb67475644f8b89ad87e12c62bbe3
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background An investigation of trends of incidence and net survival (NS) for endometrial cancer in Sweden. Methods Morphologically verified endometrial carcinoma diagnosed 1960 to 2014 were collected from the nation-wide Swedish Cancer Regis
Externí odkaz:
https://doaj.org/article/00a7bc64f44143f095d2bbfef57c5a3d
Autor:
Thomas, Hogberg
Publikováno v:
Nature reviews. Clinical oncology. 7(4)
Dose-dense administration of paclitaxel as well as intraperitoneal administration of platinum and paclitaxel as first-line treatments provide similar advantages compared with standard treatment in advanced ovarian cancer. Both approaches, however, ne
Autor:
Christer Borgfeldt, Erik Holmberg, Janusz Marcickiewicz, Karin Stålberg, Bengt Tholander, Elisabeth Åvall Lundqvist, Angelique Flöter-Rådestad, Maria Bjurberg, Pernilla Dahm-Kähler, Kristina Hellman, Elisabet Hjerpe, Preben Kjölhede, Per Rosenberg, Thomas Högberg
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The aim of this study was to analyze overall survival in endometrial cancer patients’ FIGO stages I-III in relation to surgical approach; minimally invasive (MIS) or open surgery (laparotomy). Methods A population-based retrospe
Externí odkaz:
https://doaj.org/article/a830b75315704ac186c77bcb8479087a
Autor:
Thomas Hogberg
Publikováno v:
European Oncology & Haematology. :71
Endometrial cancer generally has a good prognosis because most cases are diagnosed in stage I. It is possible to identify subgroups of patients with early-stage endometrial cancer with a poor prognosis. Despite a traditional generous use of adjuvant